Takeda Pharmaceutical (TAK) Dividend Coverage Ratio Growth (1y) (2019 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Dividend Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -3.09% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 264.24% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -129.25% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -30.09% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -92.21% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.19 Bn | 5.10 Bn | -11.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.83% |
| Sep 30, 2025 | -7.17% |
| Jun 30, 2025 | -23.99% |
| Mar 31, 2025 | -22.26% |
| Dec 31, 2024 | 415.41% |
| Sep 30, 2024 | 27.24% |
| Jun 30, 2024 | -0.87% |
| Mar 31, 2024 | -3.51% |
| Dec 31, 2023 | 75.64% |
| Sep 30, 2023 | -468.74% |
| Jun 30, 2023 | 16.09% |
| Mar 31, 2023 | -1,044.16% |
| Dec 31, 2022 | 7.28% |
| Sep 30, 2022 | -15.11% |
| Jun 30, 2022 | 21.86% |
| Mar 31, 2022 | 104.70% |
| Dec 31, 2021 | -953.41% |
| Sep 30, 2021 | -930.93% |
| Jun 30, 2021 | -68.24% |
| Mar 31, 2021 | -10,866.23% |